Sunmax Biotechnology Co (4728.TWO) Stock Price
Sunmax Biotechnology Co Price
Over the last 19 years Sunmax Biotechnology Co grew revenue by 28.0% annually, reaching 2.03 B TWD. Earnings per share have grown at 23.6% per year over the last 15 years. For Sunmax Biotechnology Co, the net margin of 35.8% is up versus 23.7% a few years ago. At today's price the dividend yield works out to roughly 2.93%. The payout ratio is around 87% of earnings. The dividend has grown at 38.1% per year over the past 3 years.
Sunmax Biotechnology Co stock price
Sunmax Biotechnology Co business model & stock analysis
Frequently asked questions about Sunmax Biotechnology Co
Converted at the current exchange rate, the Sunmax Biotechnology Co share trades at 11.10 EUR (396.00 TWD).
The revenue cannot currently be calculated for Sunmax Biotechnology Co.
The profit cannot currently be calculated for Sunmax Biotechnology Co.
The P/E ratio cannot be calculated for Sunmax Biotechnology Co at the moment.
The P/S cannot be calculated for Sunmax Biotechnology Co currently.
The Eulerpool Quality Score for Sunmax Biotechnology Co is 7/10.
The ISIN of Sunmax Biotechnology Co is TW0004728001. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Sunmax Biotechnology Co is 4728.TWO. The ticker symbol is used to trade Sunmax Biotechnology Co shares on the stock exchange.
Sunmax Biotechnology Co stock
Sunmax Biotechnology Co Peer Group
Sunmax Biotechnology Co FIGI
All fundamentals and in-depth analysis of Sunmax Biotechnology Co
Our stock analysis for Sunmax Biotechnology Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sunmax Biotechnology Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.